Evotec SE Profit Margin

The latest profit margin for EVT.DE is -27.78% as of June 2026. That compares with -20.01% in the prior-year period — down 38.8% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Evotec SE's historical trend and sector peers before judging valuation or financial health.

Over the past year, EVT.DE's profit margin moved from -20.01% to -27.78% — a 38.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Evotec SE's valuation or profitability profile.

Against Healthcare companies, EVT.DE currently prints -27.78% for profit margin, while the sector average sits near 9.48%. That is roughly 393.0% below the sector mean. Large gaps often invite a closer look at Evotec SE's growth, margins, and balance sheet.

Profit Margin shows how effectively Evotec SE converts resources into returns. At -27.78%, EVT.DE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -20.01% in the prior-year period — down 38.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting EVT.DE's profit margin (-27.78%), review year-over-year change from -20.01%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.